Search Results - PHARMACOLOGY OF DRUGS AFFECTING THE CARDIOVASCULAR SYSTEM

Refine Results
  1. 1

    Drug Repositioning Applied to Cardiovascular Disease in Mucopolysaccharidosis by Gerda Cristal Villalba Silva, Thiago Steindorff, Roselena Silvestri Schuh, Natalia Cardoso Flores, Ursula Matte

    Published in Life (2022-12-01)
    Get full text
    Article


  2. 2

    Role of Arginase 2 as a potential pharmacological target for the creation of new drugs to correct cardiovascular diseases by Sergey A. Demchenko, Ivan S. Koklin, Natalia Yu. Koklina

    Published in Research Results in Pharmacology (2020-03-01)
    “…The modern possibilities of treatment of endothelial dysfunction in the pathology of the cardiovascular system and the possibility of creation of new drugs are considered. …”
    Get full text
    Article


  3. 3

    Pharmacogenetics of cardiovascular drugs by Pajović Vladislav, Žigon Nina

    Published in Medicinski Podmladak (2023-01-01)
    “…Individual variations in the patient's response to the administered drugs are a frequent and important clinical problem in medicine and pharmacology. …”
    Get full text
    Article


  4. 4

    A quantitative systems pharmacology approach to predict the safe‐equivalent dose of doxorubicin in patients with cardiovascular comorbidity by Lan Sang, Yi Yuan, Ying Zhou, Zhengying Zhou, Muhan Jiang, Xiaoquan Liu, Kun Hao, Hua He

    “…In this study, a translational quantitative system pharmacology‐pharmacokinetic‐pharmacodynamic (QSP‐PK‐PD) model was developed based on preclinical study to predict the safe‐equivalence dose of doxorubicin in patients with or without cardiovascular disease. …”
    Get full text
    Article


  5. 5

    Pharmacogenomics and circadian rhythms as mediators of cardiovascular drug-drug interactions by Yong-Jian Geng, Rosalinda Madonna, Ramon C. Hermida, Michael H. Smolensky

    Get full text
    Article


  6. 6

    Advances in understanding the renin-angiotensin-aldosterone system (RAAS) in blood pressure control and recent pivotal trials of RAAS blockade in heart failure and diabetic nephrop... by Lama Ghazi, Paul Drawz

    Published in F1000Research (2017-03-01)
    Get full text
    Article


  7. 7

    Redefining space pharmacology: bridging knowledge gaps in drug efficacy and safety for deep space missions by Karen Barchetti, Karen Barchetti, Karen Barchetti, Audrey Derobertmasure, Audrey Derobertmasure, Audrey Derobertmasure, Pierre Boutouyrie, Pierre Boutouyrie, Pierre Boutouyrie, Piero Sestili

    Published in Frontiers in Space Technologies (2024-10-01)
    “…These alterations can potentially influence drug pharmacokinetics and pharmacodynamics, affecting the efficacy and safety of medications administered to astronauts. …”
    Get full text
    Article


  8. 8

    Metabolic Modulators in Cardiovascular Complications of Systemic Lupus Erythematosus by Sofía Miñano, Cristina González-Correa, Javier Moleón, Juan Duarte

    Published in Biomedicines (2023-11-01)
    Get full text
    Article


  9. 9

    Modulation of Reactive Oxygen Species Homeostasis as a Pleiotropic Effect of Commonly Used Drugs by Carolin Thomas, Lia Wurzer, Ernst Malle, Michael Ristow, Corina T. Madreiter-Sokolowski

    Published in Frontiers in Aging (2022-06-01)
    “…Consequently, modulation of ROS homeostasis by nutrition, exercise, or pharmacological interventions is critical in aging. Numerous nutrients and approved drugs exhibit pleiotropic effects on ROS homeostasis. …”
    Get full text
    Article


  10. 10

    Reports of Symptoms Associated with Supraventricular Arrhythmias as a Serious Adverse Drug Reaction in the Spanish Pharmacovigilance Database by Javier Pueyo-Val, Ana Avedillo-Salas, Pablo Berdún-Viñegra, Olga María Pueyo-Val, Ana Fanlo-Villacampa, Cristina Navarro-Pemán, Francisco Javier Lanuza-Giménez, Ignatios Ioakeim-Skoufa, Jorge Vicente-Romero

    Published in Pharmaceuticals (2023-08-01)
    Get full text
    Article


  11. 11

    Evaluation of therapeutic strategies targeting BCAA catabolism using a systems pharmacology model by Veronika Voronova, Victor Sokolov, Victor Sokolov, Yannick Morias, Malin Jonsson Boezelman, Maria Wågberg, Marcus Henricsson, Karl Hansson, Alexey Goltsov, Alexey Goltsov, Kirill Peskov, Kirill Peskov, Kirill Peskov, Monika Sundqvist

    Published in Frontiers in Pharmacology (2022-11-01)
    Get full text
    Article


  12. 12

    POTENTIAL NEGATIVE EFFECTS OF OSTEOARTHRITIS ON THE CARDIOVASCULAR SYSTEM AND THE ROLE OF REHABILITATION IN THEIR REDUCTION by G.Мratskova

    Published in Trakia Journal of Sciences (2025-10-01)
    “…Another mechanism affecting the cardiovascular system is the use of medication to control osteoarthritis symptoms. …”
    Get full text
    Article


  13. 13

    The effects of angiotensinogen gene polymorphisms on cardiovascular disease outcomes during antihypertensive treatment in the GenHAT study by Anh N. Do, Ryan eIrvin, Amy eLynch, Donna K Arnett

    Published in Frontiers in Pharmacology (2014-09-01)
    Get full text
    Article


  14. 14

    Antiosteoporosis Effects, Pharmacokinetics, and Drug Delivery Systems of Icaritin: Advances and Prospects by Lifang Gao, Shuang-Qing Zhang

    Published in Pharmaceuticals (2022-03-01)
    “…Osteoporosis is a systemic skeletal disorder affecting over 200 million people worldwide and contributes dramatically to global healthcare costs. …”
    Get full text
    Article


  15. 15

    The Emerging Role of Epigenetic Mechanisms in the Causation of Aberrant MMP Activity during Human Pathologies and the Use of Medicinal Drugs by Hassan Sarker, Ayman Haimour, Ravneet Toor, Carlos Fernandez-Patron

    Published in Biomolecules (2021-04-01)
    Get full text
    Article


  16. 16

    S(+)-ketamin: Review of pharmacological properties and use in clinical practice (S(+)-ketamin: Pharmacology and clinical use) by Turanjanin Dragan, Rakić Goran, Drašković Biljana

    Get full text
    Article


  17. 17

    Mechanisms involved in the vasorelaxant effects produced by the acute application of amfepramone in vitro to rat aortic rings by J.S. López-Canales, J. Lozano-Cuenca, E. Muãoz-Islas, J.C. Aguilar-Carrasco, O.A. López-Canales, R.M. López-Mayorga, E.F. Castillo-Henkel, I. Valencia-Hernández, C. Castillo-Henkel

    Get full text
    Article


  18. 18

    Mechanisms involved in the vasorelaxant effects produced by the acute application of amfepramone in vitro to rat aortic rings by J.S. López-Canales, J. Lozano-Cuenca, E. Muãoz-Islas, J.C. Aguilar-Carrasco, O.A. López-Canales, R.M. López-Mayorga, E.F. Castillo-Henkel, I. Valencia-Hernández, C. Castillo-Henkel

    Get full text
    Article


  19. 19

    A Novel Alginate-Based Delivery System for the Prevention and Treatment of Pressure-Overload Induced Heart Failure by Ambrish Kumar, Marwa Belhaj, Donald J. DiPette, Jay D. Potts

    Published in Frontiers in Pharmacology (2021-02-01)
    Get full text
    Article


  20. 20

    Pharmacogenomics and non-genetic factors affecting drug response in autism spectrum disorder in Thai and other populations: current evidence and future implications by Mohitosh Biswas, Mohitosh Biswas, Mohitosh Biswas, Natchaya Vanwong, Natchaya Vanwong, Chonlaphat Sukasem, Chonlaphat Sukasem, Chonlaphat Sukasem, Chonlaphat Sukasem, Chonlaphat Sukasem

    Published in Frontiers in Pharmacology (2024-02-01)
    Get full text
    Article


Search Tools: